Press release
Global Market Analysis of COPD and Asthma Devices: Growing Demand for Inhalers and Nebulizers Driving Market Growth
COPD (Chronic Obstructive Pulmonary Disease) and Asthma are two respiratory conditions that can cause difficulty breathing, coughing, and wheezing. There are several devices available to help manage these conditions and improve breathing function.Inhalers: Inhalers are the most common devices used to treat COPD and Asthma. These devices deliver medication directly to the lungs, where it is needed. Inhalers come in different types, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers. Inhalers work by creating a fine mist or powder that is inhaled into the lungs.
The global COPD and asthma devices market size was estimated at $36.45 billion in 2019, and is anticipated to hit $51.62 billion by 2027, registering a CAGR of 4.3% from 2020 to 2027.
Download Sample Copy of this Report:
https://www.alliedmarketresearch.com/request-sample/579
Nebulizers: Nebulizers are devices that convert liquid medication into a fine mist that can be inhaled through a mask or mouthpiece. Nebulizers are often used by people who have difficulty using inhalers or for those who need higher doses of medication.
Peak Flow Meters: Peak Flow Meters are handheld devices that measure how well air moves out of the lungs. They are used to monitor lung function and to help people with Asthma or COPD identify changes in breathing function before symptoms appear.
Oxygen Therapy Devices: For people with severe COPD or Asthma, oxygen therapy devices may be necessary to deliver supplemental oxygen. These devices include oxygen tanks, oxygen concentrators, and portable oxygen tanks.
Spirometers: Spirometers are devices that measure lung function by measuring how much air is breathed in and out of the lungs. They can be used to diagnose COPD or Asthma, monitor lung function over time, and help people with these conditions develop a breathing plan.
It is important to work with a healthcare provider to determine which devices are best for managing COPD or Asthma symptoms. They can also provide guidance on how to use these devices properly and monitor lung function over time.
COVID-19 impact-
The demand for respiratory care devices including inhalers has been increased during Covid-19. Also, the international regulatory agencies have accelerated approval of several respiratory devices.
The global lockdown has disrupted the supply chain badly and as a result, the manufacturing process has also been severely hampered.
However, government bodies across the world have imposed certain relaxations to ease up the existing regulations and the global market is projected to retrieve its position soon.
For Purchase Enquiry at:
https://www.alliedmarketresearch.com/purchase-enquiry/579
The segments used in COPD and Asthma devices vary depending on the type of device. Here are the common segments for each type of device:
Inhalers: Inhalers usually consist of a canister, which contains the medication, and a plastic mouthpiece. The segments used in inhalers include the canister, mouthpiece, actuator, dose counter (in some inhalers), and cap.
Nebulizers: Nebulizers consist of a compressor, nebulizer cup, and tubing. The segments used in nebulizers include the compressor, nebulizer cup, tubing, mask or mouthpiece, and medication chamber.
Peak Flow Meters: Peak Flow Meters typically consist of a plastic meter with a mouthpiece. The segments used in peak flow meters include the meter, mouthpiece, and scale.
Oxygen Therapy Devices: Oxygen therapy devices vary in design and segments, but the common segments include oxygen tank, regulator, flow meter, humidifier bottle (in some devices), and nasal cannula or mask.
Spirometers: Spirometers consist of a handheld device with a mouthpiece and a display screen. The segments used in spirometers include the mouthpiece, display screen, and data storage capacity (in some devices).
Overall, these segments are designed to deliver medication, measure lung function, and provide supplemental oxygen for people with COPD or Asthma. It is important to understand how to use each device and its segments properly to get the most benefit from them.
North America garnered the major share in 2019 -
Based on geography, North America garnered the largest share in 2019, holding more than one-third of the global COPD and asthma devices market. This is owing to the widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases in this region. However, the region across Asia-Pacific would portray the fastest CAGR of 5.0% by 2027, due to rise in healthcare expenditure, growth in awareness of advanced portable COPD & asthma devices, and increase in disposable income in Asia-Pacific region.
Request Customization:
https://www.alliedmarketresearch.com/request-for-customization/579
Leading market players analysed in the research include
GF Health Products
GlaxoSmithKline Plc
Koninklijke Philips N.V.
Novartis AG
PARI medical Holding GMBH
Smith's Group Plc.
Aerogen, Inc.
AstraZeneca PLC
Baxter International Inc.
Boehringer Ingelheim International GmbH
3M COMPANY
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Market Analysis of COPD and Asthma Devices: Growing Demand for Inhalers and Nebulizers Driving Market Growth here
News-ID: 2942903 • Views: …
More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…

Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…

Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…

Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for COPD
Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need…
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights :
For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of…
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease…
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers…
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…